SLC13A5 and brain disorder: In the nervous system, SLC13A5 citrate transport disorders are associated with pediatric epilepsy, Kohlschütter–Tönz syndrome, and other brain disorders, leading to imbalanced metabolic homeostasis affecting brain citrate and acetyl-CoA metabolism as well as ionic homeostasis [7,12,13,24,25].